View of FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Return to Article Details FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Download Download PDF